HAPLOGEN GmbH

HAPLOGEN

[ Chemical preparations for medical purposes, namely, treatment of infectious diseases, cancer, metabolic diseases and immune diseases; ] pharmaceutical and biochemical substances and preparations, in particular, reagents for medical research applications and medical diagnosis; cell lines for medical purposes; cellular products, namely, cells and cell cultures for medical purposes, namely, target finding and validation, cell growth and resistance, sensitivity; diagnostic preparations for medical purposes;[ Chemicals for use in industry and science; ] cells for in vitro scientific and research use in laboratories and for analysis; microorganisms and cell cultures for in vitro scientific and research use; diagnostic preparations for non-medical purposes;Medical services, in particular genetic analyses for development of therapies;Scientific and medical research and development; scientific research in the field of genetic engineering; biotechnology research and development services; biotechnology professional consultancy services;